Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Minority Interest (2019 - 2025)

Historic Minority Interest for Sanara MedTech (SMTI) over the last 7 years, with Q3 2025 value amounting to -$8422.0.

  • Sanara MedTech's Minority Interest rose 9744.47% to -$8422.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$8422.0, marking a year-over-year increase of 9744.47%. This contributed to the annual value of -$491611.0 for FY2024, which is 10126.55% down from last year.
  • As of Q3 2025, Sanara MedTech's Minority Interest stood at -$8422.0, which was up 9744.47% from -$7467.0 recorded in Q2 2025.
  • Sanara MedTech's Minority Interest's 5-year high stood at -$3431.0 during Q1 2025, with a 5-year trough of -$809520.0 in Q3 2022.
  • Moreover, its 5-year median value for Minority Interest was -$304307.0 (2024), whereas its average is -$333239.4.
  • Its Minority Interest has fluctuated over the past 5 years, first tumbled by 12710.24% in 2023, then skyrocketed by 9877.08% in 2025.
  • Over the past 5 years, Sanara MedTech's Minority Interest (Quarter) stood at -$488397.0 in 2021, then skyrocketed by 77.98% to -$107555.0 in 2022, then crashed by 127.1% to -$244260.0 in 2023, then crashed by 101.27% to -$491611.0 in 2024, then skyrocketed by 98.29% to -$8422.0 in 2025.
  • Its Minority Interest stands at -$8422.0 for Q3 2025, versus -$7467.0 for Q2 2025 and -$3431.0 for Q1 2025.